Director’s Catalyst Fund
The Director’s Catalyst Fund was launched in 2016 with the support of donations, and aims to support early stage projects and innovation for early career researchers. This is often the key to supporting applications for securing highly competitive external funding.
The fund supports high-quality research projects relevant to LSTM research strategic priorities and provides pump-priming for new and innovative ideas and projects. The awardees benefit from mentorship and support from senior academic colleagues, enabling us to nurture LSTM’s research leaders of the future.
“The Director’s Catalyst Fund is intended to support early-career researchers and accelerate their transition to future international leaders. We seek to fund high-quality research projects relevant to LSTM research strategic priorities. Awardees will be provided mentorship and an excellent research environment to support their development needs and increase their chances of success”
- Evaluating novel snake venom gland organoid technology as a platform to accelerate antivenom research and development.
- Elucidating the mechanisms of action of new chemical entities and repurposed drugs against SARS-CoV-2
- Accelerating diagnosis of Crimean Congo Haemorrhagic Fever through simultaneous detection of viral antigens and IgM.
- Developing models of care for symptomatic former TB patients in urban Blantyre, Malawi